Introduction and Objective: Prolonged fasting induces a metabolic switch from glucose to ketone utilization, which may influence cognitive function and metabolic health. However, data on cognitive effects of prolonged fasting (≥24 h), ketone-confirmed metabolic switching, and sex-specific responses remain limited.Methods: In a randomized, within-subject crossover pilot study, healthy adults (18-55 years) completed a control condition […]
Read MoreCategory: Diabetes
2955-LB: Gestational Glucose Intolerance and Future Cardiovascular Disease Risk
Introduction and Objective: Gestational diabetes (GDM) increases future cardiovascular disease (CVD) risk, but the link between gestational glucose intolerance (GGI), subclinical hyperglycemia in pregnancy that does not meet criteria for GDM, and CVD is unclear. We examined the association between GGI and future CVD risk.Methods: This was a single-center, retrospective study (1998-2016) in an electronic […]
Read More1779-P: Significant Synergistic Hypoglycemic Effects in Type 2 Diabetes Mellitus by HDM1010
Introduction and Objective: Substantial research has demonstrated that glucagon-like peptide-1 receptor agonists (GLP-1RA) and sodium-glucose cotransporter 2 inhibitors (SGLT-2i) combination therapy plays an important role in the treatment of type 2 diabetes mellitus (T2DM). Here, we investigated the potential synergistic hypoglycemic effects of HDM1010, which is a combination product of HDM1002 and SGLT-2i in a […]
Read More2954-LB: The Triglyceride Response to the Rise in Estradiol in Obese Pregnancies: Implications for Fetal Overgrowth
Introduction and Objective: Maternal fasting triglycerides (FTG), mainly hepatic VLDL TG, are higher in obese pregnancies and rise substantially over gestation under the influence of a 100-fold increase in placental estradiol (EST). Historically this rise was thought to occur in a dose-dependent pattern to support maternal metabolism as glucose is spared for fetal growth. Data […]
Read More1753-P: CGM-Based Metrics in Insulin-Naive Adults with T2D Receiving IcoSema vs. Glargine U100: Post Hoc Analysis of COMBINE 4.
Introduction and Objective: IcoSema is a once-weekly combination therapy of insulin icodec + semaglutide. This post hoc analysis assessed CGM-based metrics of IcoSema vs glargine U100 using blinded CGM data from COMBINE 4, a 40-week, phase 3b trial in T2D.Methods: Adults with T2D inadequately controlled on oral glucose-lowering medications were randomized 1:1 to IcoSema or […]
Read More2953-LB: Transdifferentiation of Delta to Beta Cells during Normal and Hyperglycemic Pregnancy
Introduction and Objective: Pancreatic β-cell number increases during pregnancy to compensate for insulin resistance. While this involves β-cell proliferation a transdifferentiation from other islet cell types, such as somatostatin (Sst)-secreting δ-cells, may also occur. It is unclear whether δ-cell mass (DCM) is also increased during pregnancy, the extent to which transdifferentiation contributes to increased β-cell […]
Read More2262-P: Mendelian Randomization Supports Sex-Specific Effects of Triglycerides on Atherosclerotic Cardiovascular Disease in Type 2 Diabetes
Introduction and Objective: Hypertriglyceridemia may explain higher atherosclerotic cardiovascular disease (ASCVD) risk in women with type 2 diabetes (T2D) than men. We examined the causal relationship between triglycerides (TG) and ASCVD in men (M) and women (W) with T2D.Methods: We included participants with T2D from the Electronic Medical Records and Genomics (eMERGE) Network, who had […]
Read More2952-LB: Developmental Timing of 1-3 Butanediol Exposure Programs Offspring Metabolism and Brain Lipid Composition
Introduction and Objective: Late-stage pregnancy induces a physiological shift toward accelerated starvation, characterized by attenuated glucose use, enhanced fatty acid oxidation, and elevated circulating ketones. Ketones cross the placenta and remain key substrates postnatally, with the neonatal brain consuming ~50% of hepatic output to sustain lipid biosynthesis and energy demands. The consequences of supraphysiological ketone […]
Read More1485-P: Closing the Gap: Improving Timeliness of Glucose Monitoring and Insulin Administration in Hospitalized Adults with Diabetes
Introduction and Objective: In hospitals, point-of-care (POC) glucose checks are often disconnected from meal delivery, delaying prandial insulin beyond the therapeutic window and contributing to poor glycemic control. We evaluated the feasibility of a structured implementation project aimed at reducing POC glucose-to-insulin administration times on an inpatient medical-surgical nursing unit.Methods: Nursing staff underwent brief training […]
Read More2951-LB: MiRNA Abundance in Mesenchymal Stem Cells Exposed to Diabetes In Utero
Introduction and Objective: Mesenchymal stem cells (MSCs) from infants born to mothers with obesity and diabetes demonstrate increased adipogenic capacity, but the molecular mechanisms underlying this effect are unclear. The objective was to quantify changes in miRNA abundance in MSCs resulting from diabetes exposure and map their potential downstream pathways.Methods: Pregnant persons, 18 control and […]
Read More